NeuroMed Zlin s.r.o.
- Address
- Kotěrova 5546, 760 01 Zlín, Czechia
NeuroMed Zlin s.r.o.
NeuroMed Zlin s.r.o. is a specialized neurological research center focused on advancing treatment options for patients with chronic neurological conditions. The center demonstrates particular expertise in conducting clinical trials for patients with treatment-resistant migraine, working to identify effective preventative therapies for those who have not responded to conventional treatments.
- Migraine prevention and novel therapeutic interventions
- Dose-finding studies for neurological medications
- Clinical trials for patients with refractory headache disorders
The research team at NeuroMed Zlin specializes in evaluating innovative pharmacological approaches for migraine prophylaxis, with a focus on determining optimal dosing strategies for new therapeutic agents. Their work contributes valuable data to the development of treatment options for patients who have exhausted standard preventative therapies, addressing a significant unmet medical need in headache medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Merz Therapeutics GmbH2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merz Therapeutics GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in NeuroMed Zlin s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Clostridium Botulinum Neurotoxin Type A in Chronic Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial | Merz Therapeutics GmbH | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins | 2 | Unknown | 2025-10-06 | 2025-10-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.